Hongmeng Yu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON) (NCT06255210) | Hongmeng Yu | 2024-03-01 |
Track Hongmeng Yu automatically
Every clearance here is in the API, with alerts when new ones post.